People. Progressive. Principled

Biomarker Discovery and Verification

Biomarkers play a key role in streamlining drug development and form an integral part of all phases of clinical trials. The use of biomarkers in clinical trials has the potential to improve drug development through helping with proof of concept studies, making accurate go/no-go decisions, enhancing regulatory submissions and helping bring personalised medicine into clinical practice.

Our biomarker services portfolio offers you access to a broad range of technology platforms including our own proprietary Invader and Nucleon chemistries in support of your clinical drug development program. Our services range from DNA and RNA extraction through to downstream genomic services and bioinformatics:

Tepnel Pharma Services has experience in biomarker discovery and development in a broad range of disease areas including:


In partnership with Fios Genomics, our combined services provide a package that allows an understanding of molecular mechanisms, improvement of diagnostic / therapeutic treatment efficacy and the identification and validation of biomarkers for drug efficacy and safety.

Sections in Clinical Services

All Clinical Services

Additional Resources

Download pdfVideo

Get in touch

Your Name

Your company (required)

Your Email (required)

Your Message

This form collects your name, Company name and email address and we may use these details in the future to contact you regarding our products and services. Please read our privacy policy for full details on how we protect and manage your data.

I consent to Tepnel Pharma Services collecting my details and contacting me regarding its products and services.